(Sharecast News) - Shares in Moderna came under pressure on Friday, after fourth-quarter losses at the US biotech were bigger than expected.
The Covid-19 vaccine manufacturer posted fourth-quarter revenues of $966n, down from $2.8bn a year previously but ahead of forecasts for $942.8m.

However, net losses came in at $1.1bn,...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE